Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), and Civica, Inc. (Civica), a not-for-profit generic drug and ...

The company reported a robust set of numbers for the December quarter of FY25, with its profit nearly doubling year-on-year ...

The Electronics City flyover in Bengaluru will be closed to vehicles from 11 pm to 6 am for maintenance, with traffic ...

Sandoz reported a 9% growth in net sales of generics and biosimilars to third parties for 2024, marking a strong first ...

The company announced that it has secured three orders valued at around ₹500 crore from Power Grid Corporation of India Ltd ...

Pharma major, Biocon Pharma, has received final approvals from the U.S. Food and Drug Administration (FDA) for its ...

Biocon Ltd is quoting at Rs 320.8, up 1.91% on the day as on 12:49 IST on the NSE. The stock is up 16.87% in last one year as compared to a 0.46% slide in NIFTY and a 4.57% slide in the Nifty Pharma ...

The rise in Biocon share price came after the company announced that its wholly-owned subsidiary, Biocon Pharma, has received ...

Shares of Biocon Ltd rose 3% after Biocon Pharma received FDA approvals for cancer drugs Lenalidomide and Dasatinib, ...

The company's subsidiary, Biocon Pharma, has received final approvals for its two ANDAs - Lenalidomide capsules and Dasatinib ...